ClinConnect ClinConnect Logo
Search / Trial NCT06877559

Balloon-Assisted Enteroscopic Treatment for Phytobezoar

Launched by SHANDONG UNIVERSITY · Mar 10, 2025

Trial Information

Current as of May 09, 2025

Active, not recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new treatment method called balloon-assisted enteroscopic treatment for a condition known as phytobezoar, which refers to a type of blockage in the intestine caused by a mass of undigested plant material. The study reviews the experiences of patients who have received this treatment at our hospital to understand how safe and effective it is.

To be eligible for this study, patients needed to have undergone the balloon-assisted treatment for phytobezoar at our hospital, and their clinical data had to be complete for analysis. The trial is currently active, but it is not recruiting new participants at this time. Those who were treated can expect that their experiences will help researchers learn more about the benefits and risks of this treatment, ultimately improving care for future patients with similar conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Retrospectively collect data from patients who underwent balloon-assisted enteroscopic treatment for phytobezoar at our hospital.
  • Exclusion Criteria:
  • Patients with incomplete clinical data.

About Shandong University

Shandong University is a prestigious research institution located in Jinan, China, renowned for its commitment to advancing medical and scientific knowledge through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment conducive to groundbreaking studies that address critical healthcare challenges. Shandong University actively engages in clinical research to evaluate new therapies and interventions, contributing to the global body of medical literature and enhancing patient care. Its dedicated team of researchers and clinicians ensures adherence to the highest ethical standards and regulatory compliance, positioning the university as a key player in the field of clinical research.

Locations

Jinan, Shandong, China

Patients applied

0 patients applied

Trial Officials

Xiuli Zuo

Study Director

Qilu Hospital of Shandong University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported